Manufacturability and the Winners in Advanced Therapies
By Stephanie Vine
January 13, 2026
Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.
7 min read
False
Advertisement
Bioprocessing
The Future of Precision Medicine is Radiopharmaceuticals
By Mona-Elisabeth Rootwelt-Revheim
January 12, 2026
Here’s why so many people in the industry are excited about the potential of radiopharmaceuticals for diagnosis and treatment.
5 min read
Building the Future of RNA Manufacturing
By Stefan Lutz
January 6, 2026
Can enzyme-catalyzed processes address the limitations of traditional RNA synthesis and define the future of scalable, sustainable manufacturing of RNA therapeutics?
5 min read
Learnings from a Scope 1 and 2 Climate-Neutral Manufacturing Facility
By Sebastián Arana
December 30, 2025
Merck’s climate-neutral facility shows how sustainability, supply-chain transparency, and cultural change can scale low-carbon biomanufacturing and build long-term resilience.
2 min read
Reshaping Drug Development with Mathematical Modeling
By Peter Sargent, Mark Davies, Hayley Close
December 4, 2025
Reducing risk, increasing confidence, and enhancing precision through mathematical modeling.
6 min read
Five Tips for Optimizing Genomics Workflows
By Paul Lomax
November 28, 2025
SPT Labtech’s Paul Lomax shares five practical strategies for improving genomics workflows through automation, integration, flexibility, miniaturization, and sustainability.
3 min read
The Shift to Agile, Modular Manufacturing
November 28, 2025
As industry conversations around manufacturing change, we caught up with Cytiva’s Joe Makowiecki to discuss modular and flexible solutions.
Discussing the Big Ideas in Medicine Manufacturing
November 27, 2025
A group of experts share their thoughts on the next “big ideas” that they think will shape the near future of therapy developments.
6 min read
Breaking Down Barriers to Biosimilar Access
November 26, 2025
With new approvals for its denosumab biosimilars, Biocon Biologics is working to close gaps in access across Europe...
6 min read
Bringing New Ideas to AAV Gene Therapy
By Erik Wiklund
November 20, 2025
As safety concerns and commercial doubts threaten the AAV gene therapy field, new technologies may offer a “well-rounded” solution.
3 min read
